Chen H - Search Results

1

TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study.

Chen S, Shuangyan T, Shi F, Cai H, Wu Z, Wang L, Ma P, Zhou Y, Mai Q, Wang F, Lai J, Chen X, Chen H, Guo W. Chen S, et al. Among authors: chen x, chen h. Front Immunol. 2024 Jul 26;15:1430571. doi: 10.3389/fimmu.2024.1430571. eCollection 2024. Front Immunol. 2024. PMID: 39131156 Free PMC article.

2

Zygomatic bone metastasis from hepatocellular carcinoma and the therapeutic efficacy of apatinib: A case report and literature review.

Lei Q, Chen H, Zheng H, Deng F, Wang F, Li J, Hu J, Fu R, Zhen Z. Lei Q, et al. Among authors: chen h. Medicine (Baltimore). 2019 May;98(18):e14595. doi: 10.1097/MD.0000000000014595. Medicine (Baltimore). 2019. PMID: 31045756 Free PMC article. Review.

3

Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression.

Fu R, Jiang S, Li J, Chen H, Zhang X. Fu R, et al. Among authors: chen h. Med Oncol. 2020 Mar 12;37(4):24. doi: 10.1007/s12032-020-01350-4. Med Oncol. 2020. PMID: 32166604

4

Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy versus lenvatinib alone for advanced hepatocellular carcinoma.

He MK, Liang RB, Zhao Y, Xu YJ, Chen HW, Zhou YM, Lai ZC, Xu L, Wei W, Zhang YJ, Chen MS, Guo RP, Li QJ, Shi M. He MK, et al. Ther Adv Med Oncol. 2021 Mar 25;13:17588359211002720. doi: 10.1177/17588359211002720. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33854567 Free PMC article.

5

Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study.

Chen S, Wu Z, Shi F, Mai Q, Wang L, Wang F, Zhuang W, Chen X, Chen H, Xu B, Lai J, Guo W. Chen S, et al. Among authors: chen x, chen h. J Cancer Res Clin Oncol. 2022 Aug;148(8):2115-2125. doi: 10.1007/s00432-021-03767-4. Epub 2021 Aug 28. J Cancer Res Clin Oncol. 2022. PMID: 34453221 Free PMC article.

6

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial.

Li QJ, He MK, Chen HW, Fang WQ, Zhou YM, Xu L, Wei W, Zhang YJ, Guo Y, Guo RP, Chen MS, Shi M. Li QJ, et al. J Clin Oncol. 2022 Jan 10;40(2):150-160. doi: 10.1200/JCO.21.00608. Epub 2021 Oct 14. J Clin Oncol. 2022. PMID: 34648352 Clinical Trial.

7

Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular Carcinoma.

Xu YJ, Lai ZC, He MK, Bu XY, Chen HW, Zhou YM, Xu L, Wei W, Zhang YJ, Chen MS, Guo RP, Shi M, Li QJ. Xu YJ, et al. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211063848. doi: 10.1177/15330338211063848. Technol Cancer Res Treat. 2021. PMID: 34898313 Free PMC article.

8

Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study.

Li SH, Mei J, Cheng Y, Li Q, Wang QX, Fang CK, Lei QC, Huang HK, Cao MR, Luo R, Deng JD, Jiang YC, Zhao RC, Lu LH, Zou JW, Deng M, Lin WP, Guan RG, Wen YH, Li JB, Zheng L, Guo ZX, Ling YH, Chen HW, Zhong C, Wei W, Guo RP. Li SH, et al. J Clin Oncol. 2023 Apr 1;41(10):1898-1908. doi: 10.1200/JCO.22.01142. Epub 2022 Dec 16. J Clin Oncol. 2023. PMID: 36525610 Free PMC article. Clinical Trial.

9

Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based on hepatic arterial infusion chemotherapy: a multicenter, retrospective study.

Deng M, Lei Q, Wang J, Lee C, Guan R, Li S, Wei W, Chen H, Zhong C, Guo R. Deng M, et al. Among authors: chen h. Int J Surg. 2023 May 1;109(5):1299-1310. doi: 10.1097/JS9.0000000000000376. Int J Surg. 2023. PMID: 37038994 Free PMC article.

10

Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study.

Chen S, Shi F, Wu Z, Wang L, Cai H, Ma P, Zhou Y, Mai Q, Wang F, Tang S, Zhuang W, Lai J, Chen X, Chen H, Guo W. Chen S, et al. Among authors: chen x, chen h. J Hepatocell Carcinoma. 2023 Jul 27;10:1209-1222. doi: 10.2147/JHC.S417550. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37533600 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93,599 results

Search Page

Filters